Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 16INDUSTRY 6NETWORK 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Sarcoma 2Neuroblastoma 2Rhabdomyosarcoma 1Osteosarcoma 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Malignant mesenchymal tumor 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 18Vincristine 13Filgrastim 13Doxorubicin 13Carboplatin 13Etoposide 12Granulocyte Colony-Stimulating Factor 10Isotretinoin 9Cisplatin 9Topotecan 8Peripheral Blood Stem Cell Transplantation 8sargramostim 7Melphalan 7Radiotherapy 6etoposide phosphate 5Thiotepa 5Polymerase Chain Reaction 5Platinum 5Magnetic Resonance Spectroscopy 4Irinotecan 4Immunohistochemistry 4Gene Expression Profiling 4Colony-Stimulating Factors 41,2-diaminocyclohexaneplatinum II citrate 4lorukafusp alfa 3dinutuximab 3Temozolomide 3Stem Cell Transplantation 3Specimen Handling 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neuroblastoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT01334515 2019-10-21

Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma

Children's Oncology Group

Phase 2 Completed
52 enrolled 11 charts
CNS

Neuroblastoma

NCT00003093 2014-08-01

Combination Chemotherapy in Treating Children With Neuroblastoma

Children's Oncology Group

Phase 3 Completed
573 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡